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ABSTRACT  
Access to structured psychological therapy recommended for bipolar disorder (BD) is poor.  The UK 
NHS Improving Access to Psychological Therapies initiative commissioned a demonstration site for 
BD to explore the outcomes of routine delivery of psychological therapy in clinical practice, which 
this report summarises.  
All clinically diagnosed patients with BD who wanted a psychological intervention and were not in 
acute mood episode were eligible. Patients were offered a 10-session group intervention (Mood on 
Track) which delivered NICE congruent care. Outcomes were evaluated using an open 
(uncontrolled), pre-post design.  
Access to psychological therapy increased compared to preceding 6 years by 54%.  202 people began 
treatment; 81% completed > 5 sessions; median 9 sessions (range 6-11).  Pre-post outcomes 
included personal recovery (primary outcome), quality of life, work and social functioning, mood and 
anxiety symptoms (secondary outcomes). Personal recovery significantly improved from pre to post-
therapy; medium effect-size (d=.52). Secondary outcomes all improved (except mania symptoms) 
with smaller effect sizes (d=. 20-.39). Patient satisfaction was high. Use of crisis services, and acute 
admissions were reduced compared to pre-treatment.   
It is possible to deliver group psychological therapy for bipolar disorder in a routine NHS setting. 
Improvements were observed in personal recovery, symptoms and wider functioning with high 
patient satisfaction and reduced service use. 
Highlights 














• Most people offered therapy accepted and completed it 
• Post therapy improvements were found for personal recovery and most secondary 
functional and symptom outcomes 
• It is possible to deliver effective psychological treatment for bipolar disorder in NHS settings 
Keywords:  Service delivery, psychological treatment, implementation, bipolar disorder  
1. Introduction  
Bipolar disorder (BD) is a potentially lifelong mental health problem characterised by 
fluctuating episodes of mania and depression with often extended periods of subsyndromal 
mood symptoms in between episodes (Goodwin & Jamison, 2007; Merikangas et al., 2007). 
Many people with BD experience poor clinical outcomes, and low quality of life (IsHak et al., 
2012), and are at significant risk for suicide and self-harm (Clements et al., 2015; Clements 
et al., 2013). Although there is evidence for the efficacy of medication in prophylaxis for 
bipolar relapse, it is only partially effective (Geddes & Miklowitz, 2013). Thus in 1469 
patients in the Systematic Treatment Enhancement Programme for Bipolar Disorder,  416  
of the 858 who achieved symptomatic recovery relapsed within 2 years; predominantly with 
depressive (n=298) rather than manic, or mixed  (n=118) episodes. This was despite training 
all programme clinicians in evidence-based prescribing guidelines (Perlis et al., 2006). In a 
meta-analysis of the efficacy of lithium therapy for relapse prevention in bipolar disorder, 
relapse risk was reduced from 60% in controls to 40% in those treated by lithium, over 
follow up periods varying from 11 months to 4 years (Geddes et al., 2004). Consequently, in 
many cases BD is only partially treated due to limitations of current medications and/or 
adherence issues (NICE, 2014a).   
Cognitive therapy for bipolar disorder (CT-BD) shares an emphasis on information giving, 
and linking thoughts, feelings and behaviour to improve adaptive coping with cognitive 
therapy in general (Lam, Jones, & Hayward, 2010).  CT-BD is further informed by 
vulnerability-stress models of BD, which propose that individuals are vulnerable to circadian 
disruption, which can lead to early signs and symptoms of mood change. This is based on 
the instability of model of bipolar disorder, developed by Goodwin and Jamison (1990), 
which argues that there is a fundamental problem with the modulation of the circadian 
pacemaker in bipolar disorder, which interacts with social and psychological stressors to 
cause mood symptoms. This approach is also the cornerstone of Interpersonal and Social 
Rhythm therapy (Frank et al., 1997). The ways in which such changes are responded to, both 
cognitively and behaviourally, then influence whether there is further escalation to full 
episodes of mania or depression (Jones, 2001; Lam et al., 2010). Consequences of mood 
episodes then create social and functional disturbances, as well as experience of stigma, 
which in turn increase risks of further mood change (Brohan, Gauci, Sartorius, Thornicroft, & 
Gamian Europe Study Group, 2011; Gitlin & Miklowitz, 2017).  There is increasing evidence 
for the effectiveness of cognitive therapy and psychoeducation, which both offer evidence 













Furthermore, Kessing and colleagues have reported that combining group psychoeducation 
with optimal pharmacotherapy significantly improved rehospitalisation rates early in the 
course of bipolar disorder (<=3 prior admissions) (Kessing et al., 2013). The same team also 
explored whether this intervention had differential effects on younger (18-25 year old) vs 
older (>26 year old) patients. Neither group showed significant differences to controls on 
hazard ratio for rehospitalisation, although only younger patients experienced a significant 
reduction in total number of re hospitalisations. Kessing’s team concluded that the 
numerical scale of the point differences in hazard ratio were supportive of further 
exploration (Kessing et al., 2014). Most of the evidence cited above relates to improving 
relapse outcomes. Less is known about the impact of such approaches on personal recovery 
and quality of life, although a recent trial of recovery focused therapy had encouraging 
results (Jones et al., 2015). As NICE have highlighted, more research is needed in this area, 
as such outcomes are highly valued by individuals living with BD (NICE, 2014a). Furthermore, 
the main drivers for the cost of BD are the functional consequences of inadequate 
treatment including work performance (McCrone, Dhanasiri, Patel, Knapp, & Lawton-Smith, 
2008). 
Despite evidence for efficacy and cost-effectiveness of psychological therapy highlighted 
by NICE (NICE, 2014a, 2014b), very few people with severe mental illness are offered it 
(Haddock et al., 2014; Schizophrenia Commission, 2012). A recent NHS Trust audit specific 
to BD indicated only 8% of eligible patients were offered BD specific psychological therapy, 
despite high demand (95% of those offered treatment engaged with it; Dunn & Makin, 
2015). The urgent need to improve access to effective psychological interventions for 
people with BD was recognised by the UK Improving Access to Psychological Therapies 
(IAPT) initiative, which has already significantly improved access for people with depression 
and anxiety (Clark, 2011; Gyani, Shafran, Layard, & Clark, 2013). IAPT led a call for 
demonstration sites to pilot their Severe Mental Illness approach for people with BD, 
psychosis and personality disorder. Here we summarise uptake and outcomes from the 3 
year demonstration site for BD (January 2013 - October 2015), a joint venture between 
Birmingham and Solihull NHS Foundation trust and the Spectrum Centre for Mental Health, 
Lancaster University.  Implications of findings from this demonstration site are considered in 
relation to potential for wider national changes in provision of psychological care for BD. 
2. Method 
2.1. Service context 
Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT) serves a 
culturally and socially diverse population of 1.2 million people. It employs over 4,000 staff 
and provides care for 60,000 service users. In 2015, BSMHFT had 2166 people with a 
diagnosis of BD. The Bipolar Disorder Service (BDS) provides structured integrated 
psychological treatment for adults with BD in the Trust.  The Spectrum Centre based at 













evaluation and implementation of effective psychological interventions for bipolar disorder 
in particular.   During the IAPT SMI demonstration site period, the BDS service had 4.4 WTE 
staff (3 clinical psychologists and 1.4 WTE assistants) to deliver the Mood on Track 
Intervention. All clinicians who led groups were qualified clinical psychologists who were 
required to co-facilitate a full Mood on Track intervention before taking on a lead facilitator 
role. Data collection, analysis and reporting in relation to the demonstration site were 
registered as an approved audit by BSMHFT (Registration: 1276).  All patients provided 
consent for coded data to be collected and analysed as part of the IAPT Demonstration site 
evaluation. IAPT funding supported an extra day per week of a clinical psychologist and an 
additional assistant psychologist in BSMHFT, as well as research psychologist input from the 
Spectrum Centre to collate and analyse outcome data.  
2.2. Referrals 
As an IAPT demonstration site, the service for BD was designed for patients who were 
not in a current acute manic or depressed episode state, but wanted structured 
psychological help with living with BD.  Referrals came from Trust clinicians across BSMHFT 
including Community Mental Health Teams (CMHTs), Older adult services, Early Intervention 
services and primary care; these could be requested by the patient (<10 cases) or initiated 
by the clinician. Clinicians were aware of the MOT programme as it was part of the care 
pathway for the Trust. Patient awareness, where not prompted by a clinician, was typically 
through contact with someone who had themselves engaged in the MOT programme. All 
patients continued to receive usual clinical care from their clinical team whilst waiting for 
the MOT intervention. 
2.3. Assessments 
Each person referred was offered an assessment meeting with a trained clinical 
psychologist from the BDS with the option of bringing a friend or relative. During this 
assessment the treatment options within BDS were discussed were completed. This 
assessment was typically conducted 2-3 months after referral and was informed by clinical 
interview and review of case notes, to confirm the patient was not in an acute episode and 
that they understood the nature of the Mood on Track intervention. Self-report assessment 
data were collected for primary and secondary outcomes at baseline assessment (typically 
collected on the same day of the week 1 session of Mood on Track before the group 
formally began), mid therapy (week 4-5 depending on whether baseline was completed at 
initial assessment or in the first therapy session), end of therapy (week 10) and 3 and 6 
months post therapy.   
2.4. Therapy 
The Mood on Track (MOT) psychological intervention offered by BDS following the 













structured psychological therapy for BD indicated by NICE (2014).The original approach was 
developed by Sandra George (George, 1998) to integrate structured psychological support 
within a group format and has been updated repeatedly over time by BDS team members.  
Each session was facilitated by a Clinical Psychologist and co-facilitated, if required, by an 
Assistant Psychologist.  The sessions combined information, with interactive exercises to 
pinpoint the role of thoughts, feelings and behaviours in depression and mania, and to teach 
strategies to help individuals to monitor their mood and recognise their own early warning 
signs. These sessions also reviewed the role of circadian rhythms in regulation of mood and 
offered strategies to monitor and stabilise their social rhythms. Mindfulness was also 
addressed in the programme, as well as stress management through the use of mindfulness 
relaxation techniques. The group MOT sessions also included relapse prevention training to 
enhance coping responses to early warning signs of mania or depression. Active participant 
engagement was encouraged including opportunities to discuss and share individual 
perspectives on each session topic. See Table 1 for a summary of topics covered in each of 
the 10 sessions.  
All MOT therapists received monthly group supervision from a supervisor accredited in 
Cognitive Behavioural Therapy by the British Association for Behavioural and Cognitive 
Psychotherapy.  
2.5. Measures 
IAPT-SMI demonstration sites were tasked with instigating routine assessment and 
additionally monitoring clinical outcomes, patterns of service use and user perceptions of 
the service received. The core data set collected for the BD demonstration site is listed 
below intended to cover neglected personal recovery and quality of life outcomes along 
with assessment of manic and depressed mood.  
2.5.1. Clinical Outcome Measures  
2.5.1.1. Bipolar Recovery Questionnaire (BRQ, (Jones, Mulligan, Higginson, Dunn, & 
Morrison, 2013) 
The Bipolar Recovery Questionnaire (BRQ) was developed to provide a quantitative 
measure of personal recovery in bipolar disorder.  Patients consider their experiences in the 
past week in relation to their mental health and recovery across 36 subjective statements. 
Patients mark an ‘X’ at the point on the scale which best describes how much they agree 
with each statement (from strongly disagree to strongly agree).  Higher BRQ scores indicate 
better personal recovery.  
2.5.1.2. Bipolar Quality of Life Scale (QoL-BD, (Michalak & Murray, 2010) 
The Brief Bipolar Quality of Life Scale is a 12-item scale used to determine an 













spirituality, finance, household, self-esteem, independence and identity domains. Each item 
is rated from strongly disagree to strongly agree with higher scores reflecting better quality 
of life.  
2.5.1.3. Internal States Scale (ISS, (Bauer et al., 1991)  
The Internal States Scale (ISS) is a self-report measure used to assess mood states in 
BD. The Activation (5 items) and Wellbeing (3 items) subscales can be used together to 
evaluate manic and depressive mood states in individuals with bipolar disorder. Wellbeing 
above 125 and Activation above 155 indicates mania/hypomania whereas a score of less 
than 125 on the Wellbeing scale and less than 155 on the Activation scale indicate a 
depressed state. 
2.5.1.4. Generalised Anxiety Disorder-7 Questionnaire (GAD-7, (Spitzer, Kroenke, Williams, & 
Lowe, 2006)  
The GAD7 is a 7-item scale measuring generalised anxiety disorder. Patients reported 
frequency of anxiety problems over the previous 2 weeks on a 4-point scale (0- Not at all to 
3- Nearly every day). The total score for the GAD7 for the 7 item questionnaire ranges from 
0 to 21. A score of 0-5 represents mild anxiety, 6-10 moderate anxiety, 11-15 moderately 
severe anxiety and a score of 15-21 represents severe anxiety in a patient.  
2.5.1.5. Patient Health Questionnaire-9 (PHQ-9, (Kroenke, Spitzer, & Williams, 2001) 
The PHQ9 is a 9-item depression self-report scale. Each item was rated on a scale of 0 
(not at all) to 3 (nearly every day), in relation to the previous 2 weeks. A score of 0-4 
indicates no depression symptoms, 5-9 represents mild depression, 10-14 represents 
moderate depression, 15-19 moderately severe depression and a score of 20-27indicates 
severe depression.  
2.5.1.6. Work and Social Adjustment Scale (WASAS, (Mundt, Marks, Shear, & Greist, 2002) 
The Work and Social Adjustment Scale assesses impairments in ability to carry out 
day-to-day day tasks including work and leisure activities. Participants responded to five 
statements on a scale from 0 (not at all) to 8 (very severely) indicating impact on this aspect 
of their life. A score of 20-40 indicates moderate/ severe psychopathology; 10-20 indicates 
milder but significant functional impairment, <10 suggests absence of functional 
impairment.  
2.5.2. Service Use Data 
Service use data was collected from the electronic case record (ECR) system within 
BSMHFT with respect to crisis/home treatment team contacts and acute mental health 
admission bed days for 12 months prior to therapy, during the therapy period and post-













2.5.3. Patient Experience  
2.5.3.1. Patient Experience and Choice Questionnaire 
This 5-item questionnaire IAPT questionnaire (IAPT, 2011) is rated on a 5-point scale 
(‘At all times’ to ‘Never’) concerning ratings of their treatment experiences. This measure 
was completed at end of treatment.  
2.6. Analyses  
Baseline scores (pre-therapy) were paired with the last score available for each patient 
(post therapy) to create the paired scores consistent with previous IAPT reports (Gyani et 
al., 2013; Jolley et al., 2015). For example, if the last data point that was recorded was at 6 
months follow up, this was used in the analysis, however if this was not available either 3 
month follow up,  end of treatment  or mid therapy data was used. In order to assess the 
significance of change from pre therapy to post therapy in primary (BRQ) and secondary 
(QoL-BD, GAD7, PHQ9, WSAS, ISS-W and ISS-A). Given the work of Kessing et al (Kessing et 
al., 2014), subsidiary analyses were conducted using mixed ANOVAs to test for interaction 
between age group (18-30 vs >=31 years) and continuous outcomes. We did not split age 
groups at 25 years, as this led to sample size of only 13-14 in the younger age group 
compromising power to detect potential interactions, whereas using a cut point at 30 years 
provided a minimum of 34 younger participants. It was not possible to conduct these 
analyses on service use variables as cell sizes were too small during treatment and follow-up 
(cell sizes < 10).    
Average number of days per person per month were calculated for crisis/home 
treatment team (HTT) contacts and occupied bed days (OBD) and compared using the z test 
(Kirkwood & Sterne, 2003). Service use data compared mean monthly usage in the 12 




3.1. Demographic characteristics (Table 2) 
The sample was predominantly female and middle-aged (over half from the 36-64 age 
group). The largest ethnic group was White British; ethnic distribution of the sample was in 
line with the ethnic distribution of the Trust footprint (Solihull Observatory, 2016) for which 
the predominant grouping is white British with smaller groupings of individuals of Asian or 















3.2. Mood and functioning at Baseline (Table 3) 
Bipolar Recovery Questionnaire (BRQ) scores were below those in the development study 
of the measure (Jones, Mulligan, Higginson, Dunn, & Morrison, 2013; 2357.7 s.d. 414) 
suggesting that personal recovery levels were modest. QoL-BD scores were lower than 
those in the measure development paper and consistent with pre-intervention levels in a 
previous online intervention trial indicating modest quality of life (Michalak & Murray, 2010; 
Todd, Jones, Hart, & Lobban, 2014). GAD7 and PHQ-9 scores respectively suggested that 
patients are experiencing moderate anxiety and moderate to severe depression (Kroenke et 
al., 2001; Spitzer et al., 2006). More specifically, for GAD7, n=52 (32%) had mild/no anxiety, 
n =42 (26%) had moderate, n= 30 (18%) had moderate to severe and n= 29 (18%) had severe 
anxiety.  For PHQ-9, n =36 (23%) were experiencing no depression, n = 38 (24%) mild, n=43 
(27%) moderate and n = 43 (27%) severe depression. Internal States Scores (ISS) for 
Wellbeing and Activation indicated scores just below depression and just above hypomania 
cut offs respectively (Bauer et al., 1991; Bauer, Vojta, Kinosian, Altshuler, & Glick, 2000). ISS 
cut-offs indicated that n=116 (74%) were not depressed, whilst n= 41 (26%) were and n= 
117 (75%) were not hypomanic, whilst n=40 (25%) were reporting hypomania.  Given the 
discrepancy in depression patterns between ISS and PHQ-9 we also checked which 
individuals meet depression criteria on both measures; n =27 (17%) of those at baseline met 
criteria on both measures. WSAS scores at baseline indicated similar functional difficulties to 
those identified in large study of patients with depression (Mundt et al., 2002). Overall, this 
data suggests that patients were experiencing significant subsyndromal symptoms and 
functional difficulties at baseline.   
 
3.3. Assessment and therapy (see Figure 1)  
Between 2006-2012, BDS saw 244 patients through to completion at an average rate of 
41 per annum. In contrast, over the period January 2013 to October 2015 of IAPT-SMI pilot 
funding 166 completed treatment, representing a 54% increase to 63 per year. 
During the pilot 258 patients were assessed of whom 202 began treatment. Of the 
individuals who did not start treatment; 21 declined, 10 were deemed unsuitable for the 
service, 3 were referred elsewhere and reasons were not known for 6. The reasons why 
people declined treatment were often practical issues such as being unable to arrange time 
off work, or arranging childcare. Some patients also declined treatment due to concern 
about the group format, especially those experiencing social anxiety. The waiting time from 
referral to first treatment session was an average of 256.5 days. Of 202 people who began 
treatment, 83% completed (>5 sessions), 17% dropped out and 2% were referred to another 
service. The total number of group (MOT) sessions attended was 1419 across all patients 
who completed treatment. The median average number of sessions per patient completer 














3.4. Clinical and Functional Outcomes (see Table 3 and Supplementary Table 1)  
3.4.1. Primary outcome  
3.4.1.1. Recovery  
BRQ scores improved between pre and post therapy, difference was of medium effect 
size and statistically significant. There was no significant interaction between effect and age 
group of the patients. 
3.4.2. Secondary outcomes  
3.4.2.1. Quality of life and function  
Quality of life and social functioning as measured by QoL-BD and WASAS respectively 
improved significantly between pre and post assessments. In contrast to the personal 
recovery outcomes the effect sizes for both of these differences were small. There was no 
significant interaction between effect and age group of the patients. 
 
3.4.2.2. Mood and Anxiety Symptoms  
All measures of anxiety and low mood improved from pre to post therapy. Differences 
were significant for anxiety (GAD7) and depression (PHQ9, ISS-Well being). Manic symptoms 
showed a non-significant trend towards improvement (p <0.1). All effect sizes were small.  
There was no significant interaction between effects and age group of patients.  
 
3.5. Patient Satisfaction  
Patient Experience and Choice Questionnaire data indicated high levels of satisfaction 
with both the treatment and service in general on completion of MOT from the 98-100 
patients who provided data. As this measure was completed by participants  during the final 
few sessions (8-10) of MOT, data was not available for those who completed >5= sessions 
but <=8.  99% (n=99) felt that staff listened and treated concerns seriously all or most of the 
time, 93% (n=99) felt the service helped to address their difficulties all or most of the time, 
91% (n=97) felt that they had been involved in making choices about treatment or care all or 
most of the time, 93% (n=99) felt that they had got the help that mattered to them all or 
most of the time and 98% (n=100) had confidence in the therapist and their skills all or most 














3.6. Service use (Figures 2A and 2B) 
Average service use data (days per month) were available for all patients who 
completed treatment and who dropped out.  
Crisis contacts and acute bed days were significantly lower during treatment and follow-
up compared to pre-treatment. The only difference between those completing treatment 
and those who dropped outs was for crisis contacts which were significantly lower for 
completers at follow-up (Z = -2.91, p<.05).  
4. Discussion  
This paper evaluated, for the first time, the impact on service uptake and outcomes 
over 3 years of the sole IAPT UK demonstration site for bipolar disorder. This site was 
already delivering an established service in BSMHFT before IAPT support, which funded an 
additional MOT group annually as well as collection and analysis of outcome data Trust sites 
were accepting of to this approach during the demonstration site period. Historically, 5-6 
years ago, a number of Trust Consultants not believe or support in non-pharmacological 
treatment of this type, but by the onset of the demonstration site all clinical teams were 
willing to refer. The Mood on Track intervention was informed by principles of CBT and 
psychoeoducation, with participants actively encouraged with engage with and debate 
information provided by facilitators. Similar to Colom & Vieta’s group psychoeducation 
approach (Colom et al., 2003), MOT covers detection of early warning signs and information 
on how to respond to these as well as ways to manage stress. The interventions differ in 
that MOT is considerably shorter (10 sessions vs 21 sessions), has less of an emphasis on 
medication and use of services as the primary responses to early warning sign detection and 
stronger emphasis on psychological strategies for ongoing management.  Findings indicated 
that the structured approach to delivery and assessment of psychological care was feasible, 
acceptable and potentially effective. The demonstration site increased treatment 
completion rates compared to the previous 6-year period, with 81% of those starting 
treatment completing it. There was also evidence of improvements across a range of 
outcome measures. Primary outcome of personal recovery improved with a moderate effect 
size to post therapy. There were also significant improvements in work and social 
functioning, quality of life, anxiety and depression symptoms. IAPT Patient Experience and 
Choice Questionnaire results indicated high levels of satisfaction with the service and the 
care received with 98% reporting confidence in their therapist all or most of the time. 
Patient satisfaction data, whilst encouraging, should be treated with some caution as data 
was only available for participants who completed 8 or more sessions. Use of acute services 
including assertive outreach and hospital admission reduced during and after treatment.  
It is difficult to compare outcomes with other research due to the lack of published 
studies of routine outcomes in response to psychological therapy in BD. Oud et al (Oud et 













data considered for the NICE guideline (2014a). They reported a small effect size for change 
in depressed mood following group psychological interventions, but this was based on 
comparison at post treatment with treatment as usual participants and therefore cannot be  
directly compared.  A recent network meta-analysis of psychological therapies for bipolar 
disorder indicated that combining psychoeducation with CBT was linked to improvements in 
mania symptoms and functioning with medium and large effects respectively, but no 
significant impact on depressive symptoms (Chatterton et al., 2017). Colom and Vieta 
reported sustained effects of group psychoeducation compared to peer support on relapse 
rate, time to mood episode and hospitalisations (Colom et al., 2009; Colom et al., 2003). 
When this intervention was delivered in a UK NHS context, outside of a specialist clinic, time 
to relapse was numerically greater in those receiving group psychoeducation, but this was 
not statistically significant and there were no differences with respect depression or manic 
mood symptoms. A significant improvement in interpersonal social functioning was 
observed but not on other measures of social and occupational functioning (Morriss et al., 
2016).   Jones et al (2015) obtained a medium effect size for improvement in personal 
recovery following individual therapy in adults with recent onset bipolar disorder with 
smaller effects for quality of life and no impact on mood (Jones et al., 2015). Kessing et al’s 
finding of numerically, but not statistically significantly, better outcomes in terms of relapse 
risk for younger patients led them to argue that the effect of age on treatment outcomes 
deserved further investigation (Kessing et al., 2014). In the current report there were no 
significant interactions between membership of young <=30 years or older patient age 
groups and any of the self-reported outcomes, nor was there a numerical pattern of greater 
improvement in younger patients. Service use outcomes were not analysed by age as cell 
sizes for use during and after MOT were too small.  
There have been a small number of open trials of structured psychological treatment 
for bipolar disorder, including evaluations of group CBT, group psychoeducation and a 
remotely delivered collaborative care approach. Patelis-Siotis reported no effects on mood 
at post treatment following group CBT, but improvements in functioning and quality of life ( 
medium effects) (Patelis-Siotis et al., 2001). Provencher conducted an implementation study 
of group psychoeducation reporting post treatment improvements in knowledge about 
bipolar and depression (large and medium effects respectively) (Provencher et al., 2014). 
Finally, Bauer and colleagues identified a small, but significant, effect post-treatment for 
depression and a medium effect on mental health quality of life for their collaborative care 
intervention delivered by video conferencing (Bauer et al., 2016). A limitation of all of these 
open trials is the small samples providing data, 22-35 providing outcome data in the Patelis- 
Siotis study, 47-50 in Provencher and 79 in Bauer. Overall, MOT seems to offer benefits in 
personal recovery, functional outcomes, service use and, to a less extent, mood. Effect sizes 
were similar to, or greater than, those observed above. As noted above, for these effects to 
be directly compared to randomised controlled data a clinical and effectiveness RCT of MOT 













 The partnership between BSMHFT and Spectrum was effective in bringing together 
clinical and academic expertise in bipolar disorder. BSMHFT had an established 
infrastructure for the referral and assessment of patients with bipolar disorder within the 
Trust and expertise in the delivery of structured psychological therapy through BDS. 
Additional support in the identification and selection of standardised outcome measures 
was an important step in providing more systematic outcome data. The outcome data set 
was selected in consultation with service users in both BSMHFT and Spectrum including the 
selection of the BRQ as a measure of recovery as a primary outcome. IAPT funding provided 
additional clinical time for service delivery and assessment (0.2 WTE clinical psychologist 
and 1.0 WTE psychological assistant). This allowed extra patients to be assessed and extra 
groups delivered through the existing care pathway supported at a senior management 
level by  AG as Trust Director of Psychological services.  The service delivers psychological 
care through qualified clinical psychologists supported by assistant psychologists whose 
duties include assessment data collection.  The qualified staff had substantial experience 
working with individuals with bipolar disorder and the whole clinical team had regular 
access to clinical supervision throughout the demonstration site period.  
The data on feasibility and acceptability are relatively clear from this study. However, 
this was not an RCT and we do not have data on outcomes for individuals not offered this 
service, so definitive evaluation of effectiveness was not possible. Assessors were not blind 
and therefore it is not possible to rule out the impact of non-specific effects outside the 
intervention on the outcomes measured.  There were seven pre- post comparisons, so it is 
possible that multiple measurement might have yielded false positives. Applying Bonferroni 
correction would lead to the differences in depression no longer being significant but all 
other outcomes would stand. Applying the less conservative Glickman approach (Glickman, 
Rao, & Schultz, 2014) would conclude that depression findings remain significant. Clinical 
interviews were conducted with patients in advance before starting MOT to confirm they 
were not in an acute mood episode. Self-report data at baseline indicated 54% were 
experiencing at least moderate mood symptoms using PHQ-9, however the accuracy of this 
as a diagnostic tool has been questioned with a number of authors citing evidence of over 
diagnosis compared with other measures or clinical interview (Jerant et al., 2014; Cameron 
et al., 2008). Consistent with this using the combined data from ISS and PHQ-9 scores 
indicated that only 17% of patients met self-report criteria for depression.  
Until relatively recently there was limited evidence on the effectiveness of 
psychological interventions for bipolar disorder. As the recent NICE guidance indicates, this 
situation has now changed to a significant degree. A current challenge, recognised by NICE 
and NHS England with the Access and Waiting Times Directive 
(https://www.england.nhs.uk/wp-content/uploads/2015/02/mh-access-wait-time-guid.pdf) 
is how to increase access to structured psychological care in a systematic manner with 
routine outcome monitoring in clinical practice. The results of this demonstration site 













is accepted by patients. Based on this encouraging start it is important that other Trusts 
with less well established services for bipolar disorder are supported to adopt the successful 
approach delivered through the demonstration site.  
This service provided increased access to structured psychological therapy with 
benefits to patients in improving personal recovery, clinical outcomes and functioning. This 
demonstration site therefore provides a potential model for how to deliver psychological 
care and support in a NICE concordant manner in routine care. Evidence of reduced acute 
care service use for those offered this service suggests potential cost savings.  
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Number of people referred to 
demonstration site (n = 454) 
Number of people offered an 
assessment (n = 401) 
Number of people who attended an 
assessment (n = 258) 
Did not respond to offer of 
assessment (n=59) 
Did not attend/ arrived too 
late/cancelled too late (n = 84) 
Number of people offered 
treatment (n = 242) 
Number of people starting 
treatment (n = 202) 
Declined treatment (n = 21) 
Not suitable for the service (n = 
10) 
Referral to another service (n = 
3) 
Completed treatment (n = 167) 
Dropped out of treatment (n = 
35) 
 
Number with analysable data for 
primary outcome (n=133) 
Number with analysable data for 














Table 1  
Mood on Track session content  
 
Session  Session content  
1 What is bipolar disorder? Who develops it and how can you recognise and 
self monitor mood for risk of relapse? 
2  Understanding the roles of thoughts, feelings and behaviour in managing 
mood. What is mania? Early warning signs and the role of thinking in 
hypomania 
3  What is depression? Early signs of depression. The role of thinking in 
depression. Understanding the role of biological clocks. Managing your 
social rhythms. Establishing a healthy sleep routine 
4 Understanding medication. What it is and how it works. The function of the 
brain in mood changes. Over the counter medications and substances– 
what you need to know. The role of self-medication. Pregnancy 
5 Understanding the role of stress in bipolar disorder-how to recognise it and 
the importance of developing effective skills to manage it. Risks associated 
with bipolar disorder 
6 Supporting family members. Introduction to the potential needs of family 
members and support available  














thinking changes in hypomania. The importance of time management.  
8 Discovering strategies to lift your mood. The role of unhelpful thinking in 
depression – how to recognise it and how to use effective strategies to 
manage this. Enhancing stimulation to improve your mood. Improving your 
problem solving skills 
9 Mind and Body Stimulation Control. Introduction to and application of 
mindfulness-based approaches to calming mental and physical stimulation. 















Table 2  













Ethnic Group  
White British 63% 
Black- British Caribbean 7% 
Asian British- Pakistani 7% 
Other ethnic group 20% 














Baseline and post intervention analyses for clinical outcome measures. 
 Number of 
paired 
outcomes 










Quality of Life 
Scale 
n=161 











139 10.9 (7.1) 8.9 (6.8) p=.011, d=.22
d 
Work and Social 
Adjustment Scale 
n=155 










138 155.8 (122.1) 135.1 (110.6) p=.086, d=.15
g 
n= number of patients completing measure at baseline 
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Figure 2A.  





























































Pre-treatment During treatment Follow-up
Average acute bed days per person per month 
Completers Drop outs
* * 
* 
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